{
  "id": 21120490,
  "title": "Human health should factor in antibiotic decision, AMA says",
  "url": "https://urgent.news/2026/11/21/human-health-should-factor-in-antibiotic-decision-ama-says",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-21T21:34:51.000Z",
  "source": {
    "name": "ABC News AU",
    "slug": "abc-news-au",
    "url": "https://www.abc.net.au/news/2026-11-22/ama-florfenicol-apmva-decision-salmon-farming/107409898"
  },
  "original_language": "en",
  "account": "The Australian Medical Association (AMA) has urged the Australian Pesticides and Veterinary Medicines Authority (APVMA) to thoroughly evaluate the health and environmental risks associated with antibiotic resistance before approving the deployment of florfenicol in Tasmania for farmed salmon. The AMA warns that the consequences for human health, the environment, and market access may be underestimated. Florfenicol was initially approved in response to a bacterial disease that caused the deaths of 15,000 tonnes of salmon in early 2025, resulting in the detection of the antibiotic in wild fish up to 10 kilometres from the affected salmon pens. The regulator revoked the emergency permit in March due to \"unacceptable risk of residue exposure to non-target species.\" Salmon Tasmania has requested the APVMA's approval for another emergency-use permit with the same dosage and treatment frequency. Industry leaders argue that vaccination and selective breeding are the primary defense against disease, and antibiotics are only used to treat diagnosed infections under veterinary prescription. However, the AMA argues that the antibiotic residue cannot be contained, and exposure to aquatic workers, divers, processors, and coastal communities could lead to resistant infections, which are harder to treat and increase the burden on health systems. The AMA emphasizes the need for a full assessment of the drug's environmental and public health effects, considering the risk of resistant bacteria and resistance genes reaching humans through water, seafood, and occupational contact.",
  "summary": "With the Tasmanian salmon industry seeking to again use an antibiotic to combat disease, the nation's peak doctors' group has urged the federal regulator to consider the human health and environmental risks before approving the request.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}